trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Visceral Pain D059265 1 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Capsule Opacification D058442 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
McCulloch MW et al. Psammaplin A as a general activator of cell-based signaling assays via HDAC inhibition and studies on some bromotyrosine derivatives. 2009 Bioorg. Med. Chem. pmid:19022675
Saha A et al. Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. 2013 Bioorg. Med. Chem. pmid:23719282
Schäfer S et al. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). 2008 Bioorg. Med. Chem. pmid:18054239
Terracciano S et al. Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222. 2010 Bioorg. Med. Chem. pmid:20381359
Chen PC et al. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. 2008 Bioorg. Med. Chem. pmid:18397827
Whitehead L et al. Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitors. 2011 Bioorg. Med. Chem. pmid:21723733
Feng T et al. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2). 2013 Bioorg. Med. Chem. pmid:23820574
Mukherjee P et al. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. 2008 Bioorg. Med. Chem. pmid:18362073
Di Micco S et al. Structural basis for the design and synthesis of selective HDAC inhibitors. 2013 Bioorg. Med. Chem. pmid:23693069
Patil V et al. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group. 2010 Bioorg. Med. Chem. pmid:19914074
Nishino N et al. Interaction of aliphatic cap group in inhibition of histone deacetylases by cyclic tetrapeptides. 2008 Bioorg. Med. Chem. pmid:17900911
Shivashimpi GM et al. Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework. 2007 Bioorg. Med. Chem. pmid:17881232
Estiu G et al. On the inhibition of histone deacetylase 8. 2010 Bioorg. Med. Chem. pmid:20472442
Kaldre D et al. Optimization of histone deacetylase inhibitor activity in non-secosteroidal vitamin D-receptor agonist hybrids. 2015 Bioorg. Med. Chem. pmid:26048026
Kiyokawa S et al. New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. 2010 Bioorg. Med. Chem. pmid:20452226
Sobolewski C et al. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells. 2015 Biomolecules pmid:26343742
Piotrowska H and Jagodzinski PP Trichostatin A, sodium butyrate, and 5-aza-2'-deoxycytidine alter the expression of glucocorticoid receptor alpha and beta isoforms in Hut-78 T- and Raji B-lymphoma cell lines. 2007 Biomed. Pharmacother. pmid:17498915
Drzewiecka H and Jagodzinski PP Trichostatin A reduced phospholipase C gamma-1 transcript and protein contents in MCF-7 breast cancer cells. 2012 Biomed. Pharmacother. pmid:22257695
Cheng SP et al. Regulation of leptin receptor expression in human papillary thyroid cancer cells. 2012 Biomed. Pharmacother. pmid:22560341
Łuczak MW and Jagodziński PP Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells. 2009 Biomed. Pharmacother. pmid:18602794
Feng W et al. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells. 2015 Biomed. Pharmacother. pmid:26349994
Samiec M et al. Trichostatin A-mediated epigenetic transformation of adult bone marrow-derived mesenchymal stem cells biases the in vitro developmental capability, quality, and pluripotency extent of porcine cloned embryos. 2015 Biomed Res Int pmid:25866813
Hou H et al. Influence of intra-articular administration of trichostatin a on autologous osteochondral transplantation in a rabbit model. 2015 Biomed Res Int pmid:25866784
Shah S et al. Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. 2015 Biomed Res Int pmid:25629043
Chan ST et al. Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. 2014 Biomed Res Int pmid:24868531
Tu CY et al. Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. 2014 Biomed Res Int pmid:24707474
Florea AM DNA methylation pyrosequencing assay is applicable for the assessment of epigenetic active environmental or clinical relevant chemicals. 2013 Biomed Res Int pmid:24093099
Ilicic M et al. Modulation of Progesterone Receptor Isoform Expression in Pregnant Human Myometrium. 2017 Biomed Res Int pmid:28540297
Bitman M et al. Valproate activates ERK signaling pathway in primary human hepatocytes. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:23073524
Bagheri-Hosseinabadi Z et al. Differentiation of human adipose-derived stem cells into cardiomyocyte-like cells in fibrin scaffold by a histone deacetylase inhibitor. 2017 Biomed Eng Online pmid:29169361
Rabineau M et al. Cell guidance into quiescent state through chromatin remodeling induced by elastic modulus of substrate. 2015 Biomaterials pmid:25453945
Barua S and Rege K The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. 2010 Biomaterials pmid:20452664
Huang JC et al. Changes in histone acetylation during postovulatory aging of mouse oocyte. 2007 Biol. Reprod. pmid:17582009
Mizutani E et al. Generation of cloned mice from adult neurons by direct nuclear transfer. 2015 Biol. Reprod. pmid:25653280
Bui HT et al. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. 2010 Biol. Reprod. pmid:20505166
Ma J et al. Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. 2001 Biol. Reprod. pmid:11369600
Bui HT et al. Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos. 2011 Biol. Reprod. pmid:21753193
Wang F et al. Dynamic reprogramming of histone acetylation and methylation in the first cell cycle of cloned mouse embryos. 2007 Biol. Reprod. pmid:17823087
Shi W et al. Induction of a senescent-like phenotype does not confer the ability of bovine immortal cells to support the development of nuclear transfer embryos. 2003 Biol. Reprod. pmid:12646489
Enright BP et al. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine. 2003 Biol. Reprod. pmid:12748129
Sakurai T et al. Induction of endogenous interferon tau gene transcription by CDX2 and high acetylation in bovine nontrophoblast cells. 2009 Biol. Reprod. pmid:19211809
Laberge RM and Boissonneault G On the nature and origin of DNA strand breaks in elongating spermatids. 2005 Biol. Reprod. pmid:15772260
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Lee HS et al. Gene expression analysis in human gastric cancer cell line treated with trichostatin A and S-adenosyl-L-homocysteine using cDNA microarray. 2004 Biol. Pharm. Bull. pmid:15467184
Kimura M et al. Dual modes of action of platelet-derived growth factor and its inhibition by trichostatin-A for DNA synthesis in primary cultured smooth muscle cells of rat aorta. 1994 Biol. Pharm. Bull. pmid:8019505
Okabe M et al. Competence effect of PDGF on Ki-67 antigen and DNA contents, and its inhibition by trichostatin-A and a butylydene phthalide BP-421 in primary smooth muscle cells of rat aorta by flow cytometry. 1995 Biol. Pharm. Bull. pmid:8787785
Chuma M et al. Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer. 2012 Biol. Pharm. Bull. pmid:22466564
Egawa K et al. Identification of active substances from Streptomyces culture fluids using p53-independent expression of p21/WAF1/Cip1 gene and their mode of action. 1998 Biol. Pharm. Bull. pmid:9781835
Ikehata M et al. Different involvement of DNA methylation and histone deacetylation in the expression of solute-carrier transporters in 4 colon cancer cell lines. 2012 Biol. Pharm. Bull. pmid:22382314
Pampalakis G and Sotiropoulou G Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. 2006 Biol. Chem. pmid:16800739
Eickhoff B et al. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. 2000 Biol. Chem. pmid:10746741
Steinbac OC et al. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus. 2000 Sep-Oct Biol. Chem. pmid:11076034
Raju I et al. Epigenetic regulation of KLK7 gene expression in pancreatic and cervical cancer cells. 2016 Biol. Chem. pmid:27279059
Klan N et al. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity. 2003 Biol. Chem. pmid:12817474
Eickhoff B et al. Trichostatin A-mediated regulation of gene expression and protein kinase activities: reprogramming tumor cells for ribotoxic stress-induced apoptosis. 2000 Biol. Chem. pmid:11154071
Mahmud N et al. Differential effects of epigenetic modifiers on the expansion and maintenance of human cord blood stem/progenitor cells. 2014 Biol. Blood Marrow Transplant. pmid:24374212
Yoshida M et al. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. 1995 Bioessays pmid:7786288
Gurgul A et al. The effect of histone deacetylase inhibitor trichostatin A on porcine mesenchymal stem cell transcriptome. 2017 Biochimie pmid:28552396
Koumbadinga GA et al. Increased stability of heterogeneous ribonucleoproteins by a deacetylase inhibitor. 2015 Biochim. Biophys. Acta pmid:25959059
Donadelli M et al. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. 2007 Biochim. Biophys. Acta pmid:17555830
Darlyuk-Saadon I et al. The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22989952
Lugrin J et al. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. 2009 Biochim. Biophys. Acta pmid:19747950
Kwon HS et al. Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression. 2006 Mar-Apr Biochim. Biophys. Acta pmid:16757381
Glenisson W et al. Histone deacetylase 4 is required for TGFbeta1-induced myofibroblastic differentiation. 2007 Biochim. Biophys. Acta pmid:17610967
Cheli Y et al. Transcriptional and epigenetic regulation of the integrin collagen receptor locus ITGA1-PELO-ITGA2. 2007 Sep-Oct Biochim. Biophys. Acta pmid:17669516
Lee KJ et al. Downregulation of a tumor suppressor RECK by hypoxia through recruitment of HDAC1 and HIF-1alpha to reverse HRE site in the promoter. 2010 Biochim. Biophys. Acta pmid:20080132
Barrasa JI et al. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells. 2012 Biochim. Biophys. Acta pmid:22227581
Hsu YF et al. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells. 2012 Biochim. Biophys. Acta pmid:22155142
Horvat T et al. Epigenetic modulation of the HeLa cell membrane N-glycome. 2012 Biochim. Biophys. Acta pmid:22192783
Zelivianski S et al. Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. 2001 Biochim. Biophys. Acta pmid:11389966
Hsu YF et al. p53 in trichostatin A induced C6 glioma cell death. 2011 Biochim. Biophys. Acta pmid:21376104
Laribee RN and Klemsz MJ Histone H4 HDAC activity is necessary for expression of the PU.1 gene. 2005 Biochim. Biophys. Acta pmid:16139904
Chen W et al. MicroRNA-455-3p modulates cartilage development and degeneration through modification of histone H3 acetylation. 2016 Biochim. Biophys. Acta pmid:27638301
Alcarraz-Vizán G et al. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma metabolic reprogramming: trichostatin A as a case study. 2014 Biochim. Biophys. Acta pmid:24368265
Hsu YF et al. MAPK phosphatase-1 contributes to trichostatin A inhibition of cyclooxygenase-2 expression in human umbilical vascular endothelial cells exposed to lipopolysaccharide. 2011 Biochim. Biophys. Acta pmid:21911040
Sharma K et al. Constitutive hyperactivity of histone deacetylases enhances radioresistance in Lepidopteran Sf9 insect cells. 2016 Biochim. Biophys. Acta pmid:26968462
Cui W et al. A SUMO-acetyl switch in PXR biology. 2016 Biochim. Biophys. Acta pmid:26883953
Gobl AE et al. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. 1999 Biochim. Biophys. Acta pmid:10500243
Kusy S et al. Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. 2005 Biochim. Biophys. Acta pmid:16005989
Stoppani E et al. Point mutated caveolin-3 form (P104L) impairs myoblast differentiation via Akt and p38 signalling reduction, leading to an immature cell signature. 2011 Biochim. Biophys. Acta pmid:21182936
Moore PS et al. Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 2004 Biochim. Biophys. Acta pmid:15363630
Schnur N et al. The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes. 2007 Biochim. Biophys. Acta pmid:17894944
Falk M et al. Chromatin structure influences the sensitivity of DNA to gamma-radiation. 2008 Biochim. Biophys. Acta pmid:18706456
Putnik J et al. The interaction of ETV6 (TEL) and TIP60 requires a functional histone acetyltransferase domain in TIP60. 2007 Biochim. Biophys. Acta pmid:17980166
Zhao TC et al. gp-91 mediates histone deacetylase inhibition-induced cardioprotection. 2010 Biochim. Biophys. Acta pmid:20433879
Dowling DP et al. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors. 2008 Biochemistry pmid:19053282
Im H et al. Histone deacetylase-dependent establishment and maintenance of broad low-level histone acetylation within a tissue-specific chromatin domain. 2002 Biochemistry pmid:12484752
Singh RK et al. Kinetic and thermodynamic rationale for suberoylanilide hydroxamic acid being a preferential human histone deacetylase 8 inhibitor as compared to the structurally similar ligand, trichostatin a. 2013 Biochemistry pmid:24079912
Schultz BE et al. Kinetics and comparative reactivity of human class I and class IIb histone deacetylases. 2004 Biochemistry pmid:15323567
Emmans VC et al. Regulation of cellular processes by PPARgamma ligands in neuroblastoma cells is modulated by the level of retinoblastoma protein expression. 2004 Biochem. Soc. Trans. pmid:15494029
Kagoshima M et al. Glucocorticoid suppression of nuclear factor-kappa B: a role for histone modifications. 2003 Biochem. Soc. Trans. pmid:12546654
Ou JN et al. Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines. 2007 Biochem. Pharmacol. pmid:17276411
Kohge T et al. Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation. 1998 Biochem. Pharmacol. pmid:9825735
Jalonen U et al. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. 2005 Biochem. Pharmacol. pmid:15710351
Brieger A et al. In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors. 2004 Biochem. Pharmacol. pmid:15183120
Place RF et al. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. 2005 Biochem. Pharmacol. pmid:15950952
Yang H et al. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. 2013 Biochem. Pharmacol. pmid:23643933
Wagner S and Roemer K Retinoblastoma protein is required for efficient colorectal carcinoma cell apoptosis by histone deacetylase inhibitors in the absence of p21Waf. 2005 Biochem. Pharmacol. pmid:15763542
Koch M et al. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. 2013 Biochem. Pharmacol. pmid:23396090
Vandergeeten C et al. HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. 2007 Biochem. Pharmacol. pmid:17386923